STAT3 and diffuse large B-cell lymphoma: In DLBCL, a natural osalmid derivative DCZ0858 blocked JAK2/STAT3 signaling and inhibited B lymphoma cell survival in a concentration- and time-dependent manner while causing no significant toxicity to normal B cells [111].